U.S. stocks ended higher on Tuesday, but hidden beneath were intriguing insider trades.

Insider buying suggests confidence in a company’s future or signals a stock as a bargain – an enticing invitation for investors. While this is just one piece of the puzzle, insider purchases can significantly bolster a conviction for a long-term investment.

Let’s delve into some recent eye-catching insider moves that have caught the market’s attention. For more, explore Benzinga’s insider transactions platform.

Breaking Down Advance Auto Parts

• The Scoop: Advance Auto Parts, Inc. AAP Director Brent Windom netted a total of 2,683 shares at an average price of $80.57, making the transaction worth approximately $216,173.
• Recent Buzz: On March 19, Mizuho analyst David Bellinger kicked off coverage on Advance Auto Parts with a Neutral rating and a target price of $78.
• Company Profile: Advance Auto Parts stands as a major retailer of aftermarket automotive products, tools, and accessories for both DIY customers and third-party vehicle repair facilities across North America.

Unveiling Guardant Health

• The Trade: Guardant Health, Inc. GH Chief Information Officer Kumud Kalia secured a total of 2,187 shares at an average price of $17.82, amounting to around $38,963.
• Recent Events: On February 22, Guardant Health provided a 2024 revenue outlook below market expectations.
• Company Focus: Located in Redwood City, California, Guardant Health specializes in liquid-based cancer diagnostics for clinical and research purposes.

Remember to stay updated with our premarket insights here.

An Inside Look at NB Bancorp

• The Inside Story: NB Bancorp, Inc. NBBK Director Joseph R. Nolan Jr purchased a total of 10,000 shares at an average price of $13.50, totaling around $135,000.
• Recent Developments: On February 29, NB Bancorp announced a rise in FY23 sales figures.
• Company Overview: Identified as the parent company of Needham Bank, NB Bancorp Inc manages banking operations.

Explore more insights, like the Fear & Greed Index, as it lingers in the ‘Greed’ territory before the Fed’s interest rate verdict.